U.S. Markets closed

ResMed Inc. (RMD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
78.44+0.81 (+1.04%)
At close: 4:04PM EDT

78.44 -0.00 (-0.00%)
After hours: 4:35PM EDT

People also watch

ResMed Inc.

9001 Spectrum Center Boulevard
San Diego, CA 92123
United States

IndustryMedical Appliances & Equipment
Full Time Employees5,250

Key Executives

Mr. Michael J. FarrellChief Exec. Officer and Director2M2.07M45
Mr. Robert A. DouglasPres and Chief Operating Officer1.54M1.48M57
Mr. Brett A. SandercockChief Financial Officer and Principal Accounting Officer756.84kN/A50
Mr. David B. PendarvisChief Admin. Officer, Global Gen. Counsel and Interim Pres of EMEA & Japan940.42k1.75M58
Mr. James HollingsheadPres of Americas884.13kN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Corporate Governance

ResMed Inc.’s ISS Governance QualityScore as of June 2, 2017 is 2. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 3; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.